Does Rallies show 13F holders for MET?

Yes. Rallies tracks hedge fund and 13F ownership data for MET, including fund names, share counts, latest tracked quarter, and position changes when available.

Is MET research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MET. It does not provide personalized investment advice.

MET (MetLife) Stock Analysis - Hedge Fund Holdings

MetLife (MET) is a publicly traded Financial Services sector company. As of May 20, 2026, MET trades at $82.40 with a market cap of $52.38B and a P/E ratio of 15.88. MET moved +1.77% today. Year to date, MET is +0.90%; over the trailing twelve months it is +2.71%. Its 52-week range spans $65.21 to $89.05. Analyst consensus is strong buy with an average price target of $93.20. Rallies surfaces MET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns MET stock?

Hedge funds tracked by Rallies that own MET include Bridgewater Associates, Panagora Asset, Pinebridge Investments, Viking Global, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MetLife.

MET Key Metrics

Key financial metrics for MET
Metric	Value
Price	$82.40
Market Cap	$52.38B
P/E Ratio	15.88
EPS	$5.20
Dividend Yield	0.59%
52-Week High	$89.05
52-Week Low	$65.21
Volume	2.09M
Avg Volume	0
Revenue (TTM)	$77.59B
Net Income	$3.62B
Gross Margin	0.00%

Top Hedge Funds Holding MET

Bridgewater Associates holds 626.53K shares of MET, changed -38.40% as of Mar 31, 2026.
Panagora Asset holds 518.07K shares of MET, changed -1.25% as of Mar 31, 2026.
Pinebridge Investments holds 87.13K shares of MET, changed +2422.67% as of Sep 30, 2024.
Viking Global holds 84.31K shares of MET, changed -98.60% as of Mar 31, 2025.
Mangrove Partners holds 9.80K shares of MET, changed +0.00% as of Dec 31, 2024.

Latest MET News

MetLife Commits $170M to Revamp Water Tower Place, Eyes Medical Office Conversion — Apr 27, 2026
MetLife jumps as life insurers catch a bid; strong 2025 results keep bulls in control — Apr 8, 2026
MetLife jumps as yields slide and quarter-end risk appetite returns — Mar 31, 2026
MetLife drops 3% as yields slide and analyst caution weighs on life insurers — Mar 27, 2026
MetLife Adds Ex-Marsh CEO Dan Glaser, Russell Investments’ Michelle Seitz to Board — Feb 24, 2026

MET Analyst Consensus

11 analysts cover MET: 0 strong buy, 9 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $93.20.

Common questions about MET

Who owns MET stock?: Hedge funds tracked by Rallies that own MET include Bridgewater Associates, Panagora Asset, Pinebridge Investments, Viking Global, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for MetLife.
Does Rallies show 13F holders for MET?: Yes. Rallies tracks hedge fund and 13F ownership data for MET, including fund names, share counts, latest tracked quarter, and position changes when available.
Is MET research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MET. It does not provide personalized investment advice.